The estimated Net Worth of Capital Group, Lpluxor Capi... is at least $71.3 Milion dollars as of 6 October 2014. Capital Capi owns over 2,472 units of Arcturus Therapeutics Inc stock worth over $585,132 and over the last 12 years Capital sold ARCT stock worth over $70,687,500.
Capital has made over 7 trades of the Arcturus Therapeutics Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently Capital bought 2,472 units of ARCT stock worth $1,664,200 on 6 October 2014.
The largest trade Capital's ever made was selling 2,827,500 units of Arcturus Therapeutics Inc stock on 21 May 2013 worth over $70,687,500. On average, Capital trades about 396,303 units every 63 days since 2013. As of 6 October 2014 Capital still owns at least 27,890 units of Arcturus Therapeutics Inc stock.
You can see the complete history of Capital Capi stock trades at the bottom of the page.
Over the last 12 years, insiders at Arcturus Therapeutics Inc have traded over $137,035,874 worth of Arcturus Therapeutics Inc stock and bought 56,234 units worth $767,374 . The most active insiders traders include William M Kahane, Nicholas S Schorsch a Peter C Farrell. On average, Arcturus Therapeutics Inc executives and independent directors trade stock every 33 days with the average trade being worth of $1,034,818. The most recent stock trade was executed by Jing L. Marantz on 14 June 2024, trading 3,131 units of ARCT stock currently worth $65,688.
founded in 2013 and based in san diego, calif., arcturus therapeutics is poised to become an industry leader in the application of rnai technologies for the treatment of disease and improved quality of life. the company’s aim is to develop breakthrough technology and novel therapeutics for rare diseases for which there is no adequate treatment. backed by a management team with extensive experience in the discovery and development of therapeutic modalities, arcturus is on the forefront of research and development of nanoparticle sirna drug delivery systems.
Arcturus Therapeutics Inc executives and other stock owners filed with the SEC include: